Radiolabeled antibody therapy of lymphoma
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 66, 127-145
- https://doi.org/10.1007/978-1-4615-3084-8_9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- THE USE OF RADIOLABELED ANTI-CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIATransplantation, 1992
- The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic studyCancer Immunology, Immunotherapy, 1991
- Advantage of Dose Fractionation in Monoclonal Antibody-Targeted RadioimmunotherapyJNCI Journal of the National Cancer Institute, 1990
- Immunoscintigraphy of Hodgkin's disease: In vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell linesEuropean Journal of Cancer and Clinical Oncology, 1990
- Treatment of Lymphoma With Radiolabeled Antibody: Elimination of Tumor Cells Lacking Target AntigenJNCI Journal of the National Cancer Institute, 1990
- The effects of tumor mass, tumor age, and external beam radiation on tumor-specific antibody uptakeInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Radioimmunodetection of Cutaneous T-Cell Lymphoma with111In-Labeled T101 Monoclonal AntibodyNew England Journal of Medicine, 1986
- The Influence of Monoclonal Antibody Dose on Tumor Uptake of Radiolabeled AntibodyCancer Drug Delivery, 1986
- Emergence of Idiotype Variants during Treatment of B-Cell Lymphoma with Anti-Idiotype AntibodiesNew England Journal of Medicine, 1985
- Immunotoxins: A New Approach to Cancer TherapyScience, 1983